10 hrs ago | biz.yahoo.com | Posted by PFH
Strength & Innovation of Novartis Oncology Pipeline Demonstrated by More Than 170 ASCO Abstracts
Novartis Oncology's cancer therapies will be the subject of more than 170 abstracts at the meeting, and will be highlighted in a plenary session, as well as seven oral presentations.
11 hrs ago | www.businessweek.com | Posted by PFH
Cancer Research Group Releases Data
Studies of drugs that may stop the spread of many cancers - vaccines for brain tumors, treatments that prevent bone metastases, vitamins that may improve the chances of breast cancer patients - will be examined ...
Thursday | www.forbes.com | Posted by PFH
Thursday | ir.imshealth.com | Posted by PFH
Continued Double-Digit Annual Growth of Cancer Therapeutics: Sales to Exceed $75 Billion by 2012
May 15, 2008--Global sales of cancer drugs will grow at a compounded annual rate of 12 to 15 percent, reaching $75 to $80 billion by 2012, according to a new forecast by IMS Health , the world's leading ...
Wednesday May 14 | online.wsj.com | Posted by PFH
Matchmakers: Patients Meet Clinical Trials
Diagnosed last fall with smoldering multiple myeloma, a slow-growing form of blood cancer, Glenn Coderre relies on his oncologist for the standard drug regimen now used to treat the disease.
Wednesday May 14 | www.nytimes.com | Posted by PFH
Cancer Patients, Lost in a Maze of Uneven Care
Cancer, more than almost any other disease, can be overwhelmingly complicated to treat. Patients are often stunned to learn that they will need not just one doctor, but at least three
Wednesday May 14 | www.bloomberg.com | Posted by PFH
What Cancer Doctors Know Kills ASCO's Book for Insider Trading
For years, the American Society of Clinical Oncology (ASCO) gave research data early to members in an embargoed book of abstracts, or summaries, that weren't supposed to be made public until the yearly meeting began. The rules have changed this year, when study data will be released all at once to doctors, media and investors tomorrow at 9 p.m.
Tuesday May 13 | blog.oncbiz.com | Posted by PFH
Foregoing ASP: Small practice oncologists enroll in CAP
Signifying a change from 2007 enrollment trends, small practice oncology groups are enrolling directly in the Medicare Part B competitive acquisition program , BioScrip and several practices shared with OBR.
Monday May 12 | CBC News
Never seen by patients, pathologists play critical role in deciding treatment
“Pathology is essential for the practice of modern oncology, and indeed the pathologist is probably the glue that holds the whole oncology team together”
As a patient, they are one kind of physician you will never see. But the decisions they make could mean the difference between life and death. via CBC News
Monday May 12 | MediLexicon
Common Laser Surgery For Uncommon Cancer - Doctors Have New Option In ...
“There was nothing. I mean, you just, every year you get your eyes examined and you can tell when you need your glasses or contacts changed, and that's what it was like”
Main Category: Cancer / Oncology Also Included In: Eye Health / Blindness Article Date: 12 May 2008 Chances are you or someone you know has had laser eye surgery to correct blurry vision. via MediLexicon